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ABSTRACT
Introduction Predicting upper limb capacity recovery 
is important to set treatment goals, select therapies and 
plan discharge. We introduce a prediction model of the 
patient- specific profile of upper limb capacity recovery 
up to 6 months poststroke by incorporating all serially 
assessed clinical information from patients.
Methods Model input was recovery profile of 450 
patients with a first- ever ischaemic hemispheric stroke 
measured using the Action Research Arm Test (ARAT). 
Subjects received at least three assessment sessions, 
starting within the first week until 6 months poststroke. 
We developed mixed- effects models that are able to 
deal with one or multiple measurements per subject, 
measured at non- fixed time points. The prediction 
accuracy of the different models was established by a 
fivefold cross- validation procedure.
Results A model with only ARAT time course, finger 
extension and shoulder abduction performed as good 
as models with more covariates. For the final model, 
cross- validation prediction errors at 6 months poststroke 
decreased as the number of measurements per subject 
increased, from a median error of 8.4 points on the 
ARAT (Q1–Q3:1.7–28.1) when one measurement early 
poststroke was used, to 2.3 (Q1–Q3:1–7.2) for seven 
measurements. An online version of the recovery model 
was developed that can be linked to data acquisition 
environments.
Conclusion Our innovative dynamic model can predict 
real- time, patient- specific upper limb capacity recovery 
profiles up to 6 months poststroke. The model can use all 
available serially assessed data in a flexible way, creating 
a prediction at any desired moment poststroke, stand- 
alone or linked with an electronic health record system.
INTRODUCTION
Predicting poststroke motor recovery is important 
to set realistic and feasible treatment goals, select 
effective therapies and determine adequate 
discharge policy and long- term management.1 In 
addition, prediction models can assist in clinical trial 
design to select patients that may benefit most for 
the treatment of interest; for example, by including 
only those patients that have the potential to benefit 
from the intervention under study.2 3 For health 
economics, prediction models allow benchmarking 
or help correct for casemix variability and for esti-
mating the expected costs in healthcare.1
Until today, a large number of prediction models 
for poststroke upper limb motor recovery have 
been developed (see for a review, see reference 2). 
Most of these models are based on clinical markers, 
such as voluntary control of shoulder abduction 
and finger extension (SAFE model) early post-
stroke4 (for a review, see reference 5). Other models 
include neurophysiological markers such as intact-
ness of the corticospinal pathway, measured with, 
for example, transcranial magnetic stimulation 
(TMS) (for review, see references 6 7).
Typically, current prediction models are devel-
oped with classic linear or logistic regression 
techniques. These models assume that candidate 
determinants and recovery outcomes are measured 
at predefined times poststroke; for example, deter-
minants assessed at 48 hours poststroke are used 
to predict recovery at 6 months poststroke.2 Classic 
regression approaches, however, have several limita-
tions. First, the accuracy of the prediction depends 
on the ability to assess patients at predefined time-
points poststroke.3 In clinical practice, measuring 
at predefined timepoints is challenging for many 
practical reasons. A second limitation of classic 
regression models is that they only predict one 
specific follow- up moment, for example, at 3 or 6 
months poststroke. To predict an outcome at any 
given moment poststroke would require a large 
number of regression models. Third, a limitation 
of regression- based models is that a nonlinear time 
course of recovery is not taken into account, as 
regression models are based on only two timepoints 
(ie, baseline and outcome).
Since prospective cohorts of stroke recovery 
with serial measurements have shown both non- 
linearity and high interindividual variability of 
stroke recovery,4 8 as an alternative to regression 
models, mixed models can be used. Mixed models 
are ideally suited when the individual trajectory 
of recovery over time is influenced by character-
istics that vary from patient to patient and explic-
itly account for the correlations between repeated 
measurements within each individual patient.5 In a 
mixed model, data from all assessments contribute 
to more precise estimates and characterise an indi-
vidual patient’s recovery pattern over time.9 Thus, 
with mixed models, more precise predictions may 
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be achieved by including multiple repeated measurements from 
an individual patient, allowing patient- specific predictions with 
limits of uncertainty and taking all serially assessed information 
of that subject into account. In such a model, each new data 
point with new health status information will decrease the uncer-
tainty of the individual prediction, taking into account changes 
in neurological status of the patient (‘dynamic prediction’).
In the current study, we aimed to develop an online- available 
mixed- effects prediction model for recovery in the first 6 months 
poststroke of the upper limb capacity, the ability to performuni-
lateral tasks like picking up a cup, transporting blocks,manip-
ulating small objects, measured with the Action Research Arm 
Test (ARAT) scores. Subsequently, we investigated how this 
dynamic model can take time- dependent clinical improvement 
of patients into account as soon as new information is available. 
After comparing several model alternatives, we cross- validated 
the accuracy of the predictions and developed an online patient- 
specific model in which the predicted outcome can be used at 
stroke units and throughout the care chain for predicting the 
recovery profile of upper limb capacity.
MATERIALS AND METHODS
Patients and measurements
We combined data on upper extremity capacity recovery in 
first- ever ischaemic anterior circulation stroke patients from 
four early poststroke prospective cohort studies with repeated 
measurements in time: the EXPLICIT,3 EPOS,10 4D- EEG11 and 
EXPLORE cohorts.
All datasets contain repeated measurements of the ARAT 
scores after the stroke. Patients in the 4D- EEG and EXPLORE 
cohorts were recruited within 3 weeks poststroke. Patients in 
the 4D- EEG study and the EXPLORE study were measured in 
the first week poststroke and after 5, 12 and 26 weeks. In the 
EXPLICIT study, patients were measured 1, 2, 3, 5, 12 and 26 
weeks poststroke and in the EPOS study in the first 3 days, at day 
5 and 9 and after 6 months. All studies included adult patients 
with a monoparesis or hemiparesis within the first 72 hours 
after stroke onset, without disabling medical history and with 
no severe deficits in communication, memory, or understanding 
that impede proper measurement performance.
Patients received standard rehabilitation treatment according 
to the Dutch rehabilitation guidelines, which are in agree-
ment with current international rehabilitation guidelines.12 13 
In the EXPLICT study (N=159), half of the patients with an 
unfavourable prognosis received electromyography- triggered 
neuromuscular stimulation and half of the patients with a favour-
able prognosis received modified constrain- induced movement 
therapy.3
Testing covariates
In line with recent international recommendations,14 upper 
extremity capacity measured with the ARAT was used as the 
dependent variable in the model. The ARAT has 19 tasks divided 
into four subdomains: grasp, grip, pinch and gross movement. 
The ARAT score ranges from 0 to a maximal score of 57 points, 
and the ARAT has excellent clinimetric properties.15 16
We included the following potential demographic and clin-
ical covariates variables during the model development: age, 
gender, affected bodyside, dominant side, Bamford scale 
(lacunar cerebral infarct/partial anterior circulation infarcts/total 
anterior circulation infarcts),17 and administration of alteplase 
(rt- PA). Neurological deficits were assessed with the National 
Institutes of Health Stroke Scale (NIHSS; range 0–42). NIHSS 
item 8 reflecting somatosensory deficit (range 0–2) and item 11 
measuring extinction and inattention (range 0–2) were used as 
separate covariates.18 In addition, we used the O- letter cancel-
lation test19 20 to assess visuospatial neglect using a cut- off of 2 
missing O’s or more on the hemiplegic side.
As time- dependent variables, we included the Fugl Meyer 
Upper Extremity (FM- UE) motor score (range 0–66).17 In addi-
tion, the item voluntary finger extension (FE: no=0 or yes=1 or 
2 points) of the FM- UE was used as a separate item for deriving 
the SAFE model. Upper and lower limb strength were measured 
with the Motricity Index leg and the Motricity Index arm score 
(range 0–99).21 22 The item ‘shoulder abduction’ was also used 
separately (six levels, range 0–33) for the SAFE model.
Prediction model development
For model fitting, we included all patients with at least three 
repeated measurements from which the first and last measure-
ments were at least 12 weeks apart. We excluded patients for the 
model fitting who showed an FM- EU decrease beyond the upper 
limit of the clinically important difference for the FM- UE (7.25) 
in the first 6 months.23 We did, however, include these patients 
in the cross- validation to present a fair estimate of prediction 
accuracy.
As a first step in the model fitting, we compared mixed- effects 
models with different time structures to investigate whether a 
nonlinear time, compared with a linear time structure, was more 
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effects (with time)
Covariate:
only shoulder abduction 




X X X       
Model 2 (all covariates, all main 
effects, only the significant 
interactions with time)
X X     X   
Model 3 (only significant main 
effects and significant interactions 
with time)
X     X X   
Model 4
(SAFE model)
X         X
Model 5
(minimal model)
X           
For further description of the models, see prediction model development in the methods. The safe model was used as the final model for cross- validation.
ARAT, Action Research Arm Test; SAFE, Shoulder- Abduction- Finger Extension model.
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appropriate to capture the mean recovery profile of the ARAT 
(fixed effects) and the subject- specific ARAT evolutions (random 
effects). For the models with nonlinear time structures, we used 
natural cubic splines with a different number of knots. The knots 
were placed at the quartile points in the case of 1, 2 and 3 knots 
and placed manually in the case of 6 knots.
Subsequently, we developed models with different fixed effect 
structures, starting from the most complex model with all covari-
ates mentioned above (see also table 1). More specifically: model 
1. ARAT scores as a function of all available covariates with their 
main effects and interaction with time; model 2. ARAT scores as 
a function of all covariates with all their main effects but only 
the significant interactions with time; model 3. ARAT scores as 
a function of only the significant main effects and the significant 
interactions with time; model 4. ARAT scores as a function of 
time, the SAFE model and their interaction with time and model 
5. ARAT scores as a function only of time.
Cross-validation and model comparison
We selected the optimal model from the above- mentioned 
models by comparing the prediction accuracy of the models. 
To express model accuracy, we calculated the absolute error 
between the predicted and the observed (true) ARAT measure-
ment and presented the distribution of the errors using box- plots 
with the median, the IQR, the lower whisker presented as Q1 - 
1.5 * IQR and the upper whisker presented as Q3 +1.5 * IQR. 
Values outside the range (Q1 - 1.5 * IQR, Q3 +1.5 * IQR] were 
considered outliers and were removed.
We performed a fivefold cross- validation procedure by split-
ting the data into five sets, fitted the models using four of them, 
and then predicting the recovery profiles for the patients from 
the fifth set. Although the model predicts the complete recovery 
profile and not only one future timepoint, to express prediction 
error, we compared predicted and actual recovery at 6 months 
poststroke. The predictions were obtained several times by 
adding an extra measurement for ARAT each time. We repeated 
this procedure 10 times.
For all analyses, R (V.3.6.1) software was used (freely available 
at https:// cran. r- project. org). The packages nlme (V.3.1.144) 
and JMbayes (V.0.8.85) were used. In particular, we used the 
function lme() from the package nlme to fit the models and the 
function IndvPred_lme() from the package JMbayes to obtain 
the dynamic predictions.
Online patient-specific prediction visualisation
To allow clinicians and researchers to use the prediction model 
for individual stroke patients, we developed an online visualisa-
tion for the real- time prediction of the recovery profile of upper 
extremity development and the 68% and 95% prediction inter-
vals, expressing the prediction uncertainty. For this, we use the 
shiny package in R to allow uploading a text file with recorded 
ARAT data and covariate data, which will automatically create a 
patient- specific prediction of the ARAT development over time.
Within our centre, we developed an infrastructure to couple 
this visualisation to data capture software (GemsTracker), so that 
recorded data from individual patients can be used to display 
the predicted outcome without further data entry or analysis. 
Finally, we published the source code of the prediction models 
web- based, allowing other centres to develop similar real- time 




The prospective data set consisted of 450 patients with a first- 
ever ischaemic hemispheric stroke (see table 2), of which 52% 
were males, mean age at baseline was 65 years, and mean 
follow- up days was 166 days. Patients were serially assessed with 
a median of six times (25% quantile: 4; 75% quantile: 8. The 
mean ARAT early poststroke was 14 (SD 19); the ARAT distri-
bution was skewed by a large sample of patients with an ARAT 
of 0 or 1 scores early poststroke and a less equal distribution of 
ARAT scores throughout the rest of the range of scores (Q1=0, 
median is 1, Q3 is 29, maximum score 56).
Figure 1 shows all 6- month recovery profiles and highlights 
five individual patients with different recovery profiles. The 
figure illustrates both the heterogeneity and non- linearity of 
the recovery, with some patients showing little or no recovery, 
others reaching the maximum ARAT score within the first 3 
weeks poststroke and again others starting with a relatively high 
Table 2 Patientcharacteristics assessed within 72 hours after stroke
  Mean (SD) or %
No of patients 450
Age (years) 64.8 (14.0)
Sex (males) 52
Type of stroke (Bamford classification)
Lacunar cerebral infarcts 48
Total anterior circulation infarcts 18
Partial anterior circulation infarcts 34
Affected body side (right) 39
Dominant hand (right) 92
Recombinant tissue plasminogen activator (yes) 23
National Institutes of Health Stroke Scale 8 (5)
Baseline Action Research Arm Test (ARAT) 14 (19)
Baseline Shoulder Abduction
No random movement 33
Random activity palpable, no movement visible 10
Random movement seeable but not seeable in total movement 
range
22
Random movement across total movement range, not possible 
against resistance
5
Random movement against resistance, but weaker than healthy 
side
Normal strength in comparison with contralateral side
21
Normal strength in comparison withcontralateral side 9
Fugl Meyer Upper Limb score (0–66) 25 (22)
Fugl Meyer finger extension (none, partial, full) 54, 20, 26
Motricity Index Arm (0–100) 38 (34)
Motricity Index Leg (0–100) 49 (33)
Neglect:
Normal (not present) 63
Inattention or extinction for 1 kind of stimulus severe hemi- 
inattention for both stimuli
17
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ARAT score already early after stroke and typically reaching the 
maximum ARAT score within a few weeks.
Prediction model development
Visual inspection of the individual repeated measurement profiles 
of the ARAT (see figure 1) indicated that the final model needs 
to allow for nonlinear evolutions over time. After comparing 
models with different nonlinear evolutions, we observed small 
differences between using two, three and six knots (See online 
supplementary figure 1). However, since the main goal was to 
use the model for predicting the recovery profile of the ARAT 
most precisely, we continued with the most flexible model based 
on six knots. This model also provided better predictions when 
checking several individual prediction plots.
Cross-validation prediction accuracy and model selection
Comparing the prediction accuracy of the different mixed- effects 
models and taking the first measurement of each patient as a 
predictor, we found mean cross- validation errors at 6 months 
poststroke of 10.1–105 ARAT points for the first, second and 
third model, 8.4 for the fourth SAFE model with only FE and 
SA and 17.3 for the fifth model that includes only time as a 
covariate (see Supplementary Figure 2 for more details). Based 
on these results, we decided to further continue with the fourth 
(SAFE) model for predicting the recovery profile of the ARAT.
Figure 2 illustrates the prediction errors at 6 months post-
stroke using the SAFE model. As shown, increasing the number 
of serial measurements decreased the absolute error of predic-
tion of ARAT from 8.4 points on the ARAT (Q1–Q3: 1.7–28.1) 
to 2.3 (Q1–Q3: 1–7.2) when seven serial measurements 
were used for predicting the outcome at 6 months, of which 
generally one measurement as 6 months poststroke, one at 3 
months poststroke, and the others between 2 days and 6 weeks 
poststroke.
Figure 3 illustrates the prediction errors for subgroups of 
patients with a lower, medium and higher baseline ARAT 
score at different time intervals of the last observed outcome 
(instead of the number of measurements visualised in figure 2. 
The 6- month prediction error was relatively small at each time 
point for patients with a higher initial ARAT score, while for the 
patients with a low initial ARAT score, the errors were large at 
baseline but decreased strongly later poststroke.
Online patient-specific prediction visualisation
Figure 4 visualises predicted recovery profiles (with a 68% and a 
95% prediction interval) using the SAFE model for two patients. 
The predicted recovery is nonlinear, especially in the patient 
with low initial ARAT scores. Patient 1 has a low ARAT scores 
at baseline and a moderate predicted ARAT score at 6 months. 
Patient 2 has a higher ARAT score at baseline and the predicted 
score at 6 months is >50 points. Prediction plots of the same 
patients as well as two additional patients, including a 68% and 
a 95% prediction interval, are shown in online Supplementary 
Figure 3.
Online access to a real- time tool to predicting upper extremity 
recovery for an individual patient can be found at https:// emcbio-
statistics. shinyapps. io/ Dyna micP redi ctio nARATapp/, including 
instructions on how to enter data from individual patients. This 
is also the model that, within our own setting, is coupled to an 
online structured data entry system called Profits), as a model of 
Figure 1 ARAT recovery profiles of all 450 patients (in grey) and four 
typical examples in bold and the dots indicating the exact measurement 
points. It can be seen that the recovery of upper extremity capacity is 
extremely diverse, both in terms of onset ARAT score and the change over 
time. Most measurements were taken approximately in the first 30 days; 
as a result, the change after this time point can be modelled less precisely. 
ARAT, Action Research Arm Test.
Figure 2 Cross- validation time- dependent accuracy of the shoulder 
abduction and finger extension (SAFE) model for predicting 6 months ARAT 
score. The accuracy was defined as the absolute difference between the 
predicted ARAT score at 6 months poststroke from the cross- validation and 
the measured ARAT score at the same time and displayed as median, (IQR: 
Q1=25th percentile and Q3=75th percentile), lower whisker presented 
as Q1–1.5 * IQR and upper whisker presented as Q3 +1.5 * IQR. The 
accuracy is displayed as a function of the number of serial measurements 
were used for predicting the outcome at 6 months, of which generally the 
last measurement was performed at 6 months poststroke, one at 3 months 
poststroke and the others between 2 days and 6 weeks poststroke. ARAT, 
Action Research Arm Test.
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how more computationally complex prediction models can be 
coupled to electronic health record data or other types of online 
healthcare data collection systems.
DISCUSSION
In the current study, we introduce an innovative mixed- effects 
model able to predict the patient- specific time course of upper 
limb recovery, including the associated limits of uncertainty 
within the first 6 months poststroke. We found that a model 
with only ARAT time course, FE and SA performed as good 
as models with more covariates for predicting the ARAT over 
time. In this final model, cross- validation prediction errors at 
6 months poststroke decreased as the number of measurements 
per subject increased, from a median error of 8.4 points on the 
ARAT when one measurement early poststroke was used, to 2.3 
for seven measurements. Linking this model with an electronic 
health record system at stroke units and rehabilitation wards 
will allow clinicians to obtain and visualise real time a patient’s 
recovery profile early poststroke.
In contrast to prognosis based on regression models, a major 
strength of current dynamic prediction modelling is that indi-
vidual patient- specific neurological and functional recovery 
profiles are taken into account. By making the model accessible 
online and potentially connected to electronic health record 
systems, professionals can obtain predictions without needing to 
perform complex computations. At any given moment in time, 
such as in individual patient consultation or multidisciplinary 
team meetings, an individual prediction of the recovery profile 
of the ARAT may be generated, taking into account all available 
data points.
We found that a model with only time- depended improve-
ments in SA and FE predicted recovery as accurately as more 
complex models that included covariates such as age, gender, 
the Bamford classification, the NIHSS or the full FM- UE score, 
which is in line with the SAFE model.10 24 25 In addition, we 
found that the predictions become more accurate when repeated 
clinical measurements became available in the first 8 weeks post-
stroke, which is in line with a recent model on FM- UE func-
tion8 and in line with the recent recommendations of the stroke 
recovery and rehabilitation round (SRRR) the Table group for 
clinical assessment.14 26 Finally, we showed that this dynamic 
model can be visualised and used online for clinicians working at 
stroke units and rehabilitation wards in an anonymised way by a 
simple text file as input, as shown in figures 3 and 4 and in the 
online application at https:// emcbiostatistics. shinyapps. io/ Dyna 
micP redi ctio nARATapp/
Since the implementation of prediction models in clinical 
care depends on the ease of use, an important benefit of the 
present algorithm is that it can be an integral part of existing 
electronic health record systems at stroke units, allowing direct 
access to the model input variables. Since the current study also 
shows that serial measurements in time after discharge from 
stroke units have an important added value in the accuracy of 
individual predictions, preferably, patient- specific prediction 
modelling should be part of electronic health record systems 
that span the entire chain of care of stroke services. The current 
Figure 3 Cross- vlidation accuracy of the fivefold cross- validation in for different levels of baseline (early poststroke) ARAT scores (left, middle and 
right panel) for the safe model as a function of the time of the last observed outcome (instead of the number of measurements used). Furthermore, we 
categorised the results by baseline ARAT group. The accuracy was defined as the difference between the predicted ARAT score at 6 months poststroke from 
the cross- validation and the measured ARAT score at the same time and displayed as median, (IQR: Q1=25th percentile and Q3=75th percentile), lower 
whisker presented as Q1–1.5 * IQR and upper whisker presented as Q3 +1.5 * IQR. The results can be different from figure 3 since some patients might 
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prognostic study further emphasises the need for consensus on 
using clinically validated assessments including neuroimaging 
within stroke services.27 28 The model and visualisation approach 
that we propose in the study can be adapted to predict also other 
outcome domains using the same mixed model approach. Since 
integrating prediction models in many clinical settings may 
not be readily available and a longitudinal data set of serially 
measured patients may be lacking, the stand- alone online tool 
presented in the current study allows all clinicians easy access to 
this model for their own patients.
A strength of our innovative statistical approach is that it is 
possible to predict a patient- specific recovery profile of the upper 
paretic limb using only simple demographic and relatively easy 
to measure clinical information from electronic health record 
systems at stroke units. After cross- validation, we showed that 
the accuracy of prediction improved by retesting patients serially 
in time. This finding further emphasises the need for building 
regional stroke services in which clinicians working in the chain 
of settings use the same core set of clinical outcomes poststroke as 
recently recommended in an international consensus meeting.29 
In the present study, we focused on predicting the ARAT as a 
showcase for dynamic prediction modelling. The next step will 
be to build patient- specific models for predicting the time course 
of basic ADLs and walking ability, including community walking 
poststroke. These steps should be seen as essential for improving 
current discharge policy and stroke management within current 
stroke services.28 For this purpose, preferably, the data entry 
should be part of the existing stroke guidelines and executed by 
clinicians who are trained to apply the clinical measurements in 
a valid way.30
The current study predicts the 6- month outcome on the ARAT 
scale based on a population of first- ever, ischaemic hemispheric 
strokes measured from 2005 onwards in the Netherlands. The 
predicted time course shown is irrespective of differences in type 
and intensity of rehabilitation therapies applied, which were 
applied according to the Dutch Stroke guidelines.30 Currently, 
the recommended amount of usual exercise therapy is only twice 
times 20 min per working day, which is probably insufficient to 
cause meaningful clinical differences in trajectories.31 However, 
one may assume that higher doses of task- specific exercise 
therapy may have caused beneficial effects and could serve in 
future models as one of the covariates.29 31 It is important to 
note, that mixed models explicitly account for the correlations 
between repeated measurements within each patient,9 avoiding 
the mathematical coupling found in studies that use a baseline 
measure to predict a change score.32–34 However, floor and 
ceiling effects, for which highly variables findings have been 
reported in literature (for review, see reference 35), may partly 
explain why prediction errors are smaller for patients with a very 
high or very low ARAT scores at 6 months. The high population 
of low ARAT scores early poststroke may decrease the quality 
of model fitting for patients with a moderate of high earlier 
ARAT scores; however, as seen in figure 3, model predictions 
for these patients were better than in patients with a low early 
ARAT score.
A limitation of our study is that we were restricted to clin-
ical time- dependent variables alone, such as synergism, strength, 
voluntary shoulder and FE. With that, our clinical model has 
room for improvement, especially in those patients with low 
baseline motor scores who may or may not show neurological 
Figure 4 Typical examples of the predicted ARAT recovery for two patients. The dotted vertical line represents the time of the last follow- up. The circles 
represent all the ARAT measurements available for that patient until that specific moment, while the solid line represents the predicted ARAT recovery. The 
shaded areas indicate the 68% (lighter shade) and 95% (darker shade) prediction intervals. from a clinical perspective, the errors in the cross- validation 
provide the best estimate of what the error in predicting the outcome for a new patient will be and may, therefore, be most clinically relevant. For each 
patient, the predicted recovery is illustrated at a first and a second time point, not necessarily corresponding to the first and second available measurements 
from a patient. The data of the same patients can be downloaded in the online APP to visualised predictions at all time points: https://emcbiostatistics.
shinyapps.io/DynamicPredictionARATapp/https://emcbiostatistics.shinyapps.io/DynamicPredictionARATapp/. ARAT, Action Research Arm Test.
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recovery. This is in line with previous studies indicating less 
accurate outcome prediction in patients with low FM- UE scores 
(<18 points) within the first week poststroke.8 We think that our 
current model may serve as a starting point for a more detailed 
stratification in recovery and rehabilitation trials, based on the 
patient’s potential for neurological and functional recovery 
poststroke. We may further refine the identified subgroups of 
recovery and increase precision at an individual level by targeting 
big data, based on the recently recommended core set of clinical 
outcomes recently suggested by the SRRR the Table group29 and 
in Europe.36 In addition, taking other time- dependent clinical 
covariates into account, such as somatosensory deficits and visuo- 
spatial neglect,37 the precision of individual time courses can 
be further improved in particular for those with a low baseline 
score on FM- UE. In addition, future studies may also investigate 
the added value of early measured neurophysiological markers 
such as TMS,38 39 Diffusion Tensor Imaging (DTI),40 41 structural 
brain scans42 and normalisation of directional symmetry40 as well 
as intactness of somatosensory systems in EEG43 for improving 
the precision of individual time courses for the ARAT. Another 
limitation is that we only have time courses up to 6- month post-
stroke. While this is often considered a final outcome whereafter 
no changes occur, several studies indicate that the ARAT score 
of these chronic stroke patients can be further improved with 
high doses of treatment.31 44 45 Such high dose treatment was not 
provided to our population and with such treatments or other 
successful interventions, predicted outcome can deviate from the 
outcome prediction provided by the current model.
A strength of our model is that we predict the exact ARAT 
score as well as prediction uncertainty. For clinical purposes, this 
level of detail may not always be needed and classifications of the 
ARAT scores in four different levels have been proposed46; such 
classifications could be directly calculated from our outcome 
prediction. Future impact studies may indicate which level of 
detail is needed for clinical care and how knowledge of predicted 
outcome for individual influences impacts the decision making 
in stroke rehabilitation.
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